Does PEMBROLIZUMAB Cause Cytopenia? 176 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Cytopenia have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
176
Reports of Cytopenia with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
15
Deaths
45
Hospitalizations
How Dangerous Is Cytopenia From PEMBROLIZUMAB?
Of the 176 reports, 15 (8.5%) resulted in death, 45 (25.6%) required hospitalization, and 8 (4.5%) were considered life-threatening.
Is Cytopenia Listed in the Official Label?
Yes, Cytopenia is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Cytopenia?
RITUXIMAB (1,372)
LENALIDOMIDE (1,252)
DEXAMETHASONE (1,193)
CYCLOPHOSPHAMIDE (1,191)
VENETOCLAX (1,019)
METHOTREXATE (955)
ETOPOSIDE (854)
CARBOPLATIN (754)
DOXORUBICIN (709)
VINCRISTINE (648)
Which PEMBROLIZUMAB Alternatives Have Lower Cytopenia Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G